September 28, 2016 7:49 AM ET

Biotechnology

Company Overview of Celgene Srl

Company Overview

Celgene Srl discovers, develops, and commercializes drugs and therapies to treat cancer and inflammatory diseases in Italy. It markets and sells REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID for the treatment of multiple myeloma; and VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and acute myeloid leukemia (AML). The company is based in Milan, Italy. Celgene Srl operates as a subsidiary of Celgene Corporation.

Viale Della Liberazione 13

Milan, MI 20124

Italy

Phone:

39 02 636901

Key Executives for Celgene Srl

Celgene Srl does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
AdriaCell Srl Europe
AEB SPA Europe
APAvadis Biotechnologies Europe
Arterra Bioscience s.r.l. Europe
Axxam SpA Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Celgene Srl, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.